跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KRABEVA 400 mg per 16 ml - SFDA Drug Approval Details
Approvals
/
SFDA
/
KRABEVA 400 mg per 16 ml
Authorized
BIOLOGICAL
KRABEVA 400 mg per 16 ml
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
07203b09a3cce96a
Company
Unknown
Type
Biological
Approval Details
Approval Id
07203b09a3cce96a
Drug Approval Sfda Name
KRABEVA 400 mg per 16 ml
Trade Name
KRABEVA 400 mg per 16 ml
Generic Name
Bevacizumab
Register Number
0905245271
Register Year
2024
Drug Type
Biological
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Size
16
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
Store in a refrigerator (2°C – 8°C), do not freeze
Shelf Life
24 Months
Distribution Site
Hospital
Description Code
7000000146-25-100000073871
Price
2666.35
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
07203b09a3cce96a
Type
Biological
Back to SFDA Approvals